Carlsmed, Inc Common Stock

Yahoo Finance • 19 days ago

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

Earnings Call Insights: Carlsmed (CARL) Q1 2026 MANAGEMENT VIEW * "We delivered strong revenue of $16.1 million, representing growth of 58% over the prior year." (Co-Founder, Chairman, CEO & President Michael Cordonnier) * "Operation... Full story

Yahoo Finance • 2 months ago

Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on... Full story

Yahoo Finance • 3 months ago

Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference

Carlsmed logo Key Points aprevo Technology Platform delivers patient-specific 3D surgical planning, on‑demand 3D‑printed implants and sterile single‑use instruments across the pre/intra/post‑op workflow; the company has expanded into cer... Full story

Yahoo Finance • 3 months ago

Carlsmed targets $70M–$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook

Earnings Call Insights: Carlsmed, Inc. (CARL) Q4 2025 MANAGEMENT VIEW * CEO Michael Cordonnier reported, "2025 was a rapid growth year for Carlsmed and I could not be prouder of what our team has accomplished to advance our mission of... Full story

Yahoo Finance • 3 months ago

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2... Full story

Yahoo Finance • 6 months ago

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

CARLSBAD, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion surgeries. Surgeons involv... Full story

Yahoo Finance • 6 months ago

European beverage stocks trades at deep discounts

Investing.com -- European beverage stocks will enter 2026 offering broad valuation appeal after another year of weak share price performance, though the sector remains cheap for a reason and will require clearer delivery on earnings to unl... Full story

Yahoo Finance • 6 months ago

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Heal... Full story

Yahoo Finance • 7 months ago

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance

Third quarter revenue of $13.1 million, representing 98% growth YoY Raising full year 2025 revenue guidance to $49 million - $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or t... Full story

Yahoo Finance • 7 months ago

Carlsberg (CPSE:CARL B): Exploring Value After Recent Share Price Dip

Carlsberg (CPSE:CARL B) shares have quietly shifted over the past month, down nearly 4%. This recent move invites a closer look at how the company is performing in today's evolving beverage market. See our latest analysis for Carlsberg.... Full story

Yahoo Finance • 7 months ago

How Carlsberg's UK Soft Drinks Expansion With PepsiCo Has Changed Its Investment Story (CPSE:CARL B)

Carlsberg Britvic, in partnership with PepsiCo, recently announced an exclusive UK distribution agreement for Poppi, a US prebiotic soda brand, and is exploring further portfolio expansion with Mexican-style beer and functional soft drinks... Full story

Yahoo Finance • 8 months ago

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the appointment of... Full story

Yahoo Finance • 8 months ago

Carlsmed joins Russell 2000 Index following Q3 IPO

* Carlsmed (NASDAQ:CARL [https://seekingalpha.com/symbol/CARL]) added to the Russell 2000 Index effective after market close on September 22, 2025. * Inclusion follows Carlsmed’s IPO in July 2025, part of Q3 index rebalancing. * Sour... Full story

Yahoo Finance • 8 months ago

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that effective aft... Full story

Yahoo Finance • 8 months ago

Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks

The stock markets are at record highs, having shown a solid recovery from their sharp losses in April. Year-to-date, the S&P 500 is up 11% and the NASDAQ is up 13.5%, reflecting continued positive sentiment. Elevate Your Investing Strateg... Full story

Yahoo Finance • 8 months ago

Carlsberg (CPSE:CARL B): Exploring Valuation After Recent Quiet Share Price Drift

Carlsberg (CPSE:CARL B) has been on the radar lately as its shares have drifted lower in recent weeks, even though there has been no headline-grabbing event to drive the moves. Sometimes, it is the subtle shifts that spark the biggest ques... Full story

Yahoo Finance • 9 months ago

Carlsmed, Inc. Q2 Sales Increase

(RTTNews) - Carlsmed, Inc. (CARL) released Loss for second quarter of -$6.77 million The company's earnings totaled -$6.77 million, or -$1.47 per share. This compares with -$6.28 million, or -$1.55 per share, last year. The company's re... Full story

Yahoo Finance • 9 months ago

UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company... Full story

Yahoo Finance • 9 months ago

Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company... Full story

Yahoo Finance • 9 months ago

Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential

Investing.com - Piper Sandler initiated coverage on Carlsmed Inc (NASDAQ:CARL) with an Overweight rating and a price target of $18.00 on Monday. The company, currently valued at $360 million, has shown strong gross margins of 74% despite n... Full story